Rosuvastatin in patients undergoing hemodialysis.
Ganguli
Anirban
A
D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D015986:Confounding Factors, Epidemiologic; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D054559:Hyperphosphatemia / Q000150:complications*; D017379:Hypertrophy, Left Ventricular / Q000150:complications; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D010758:Phosphorus / Q000097:blood; D011743:Pyrimidines / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D010758:Phosphorus; D000068718:Rosuvastatin Calcium